Industry Research Reports

Home > Reports > Pharma & Healthcare > Measle Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Measle Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-16

Pages: 83 Pages

Report ld: 2222918

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.

The global market for Measle Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Measle Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Measle Vaccine by region & country, by Type, and by Application.

The Measle Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measle Vaccine.

Market Segmentation

Report Metric
Details
Report Title
Measle Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Measle Vaccine Companies Covered
Merck, Biovac, McKesson Medical
Global Measle Vaccine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Measle Vaccine Market, Segment by Type
Inactivated Vaccine

Attenuated Vaccine
Global Measle Vaccine Market, Segment by Application
Hospital

Scientific Research

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Measle Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Measle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Measle Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Measle Vaccine Product Introduction
    1.2 Global Measle Vaccine Market Size Forecast
        1.2.1 Global Measle Vaccine Sales Value (2019-2030)
        1.2.2 Global Measle Vaccine Sales Volume (2019-2030)
        1.2.3 Global Measle Vaccine Sales Price (2019-2030)
    1.3 Measle Vaccine Market Trends & Drivers
        1.3.1 Measle Vaccine Industry Trends
        1.3.2 Measle Vaccine Market Drivers & Opportunity
        1.3.3 Measle Vaccine Market Challenges
        1.3.4 Measle Vaccine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Measle Vaccine Players Revenue Ranking (2023)
    2.2 Global Measle Vaccine Revenue by Company (2019-2024)
    2.3 Global Measle Vaccine Players Sales Volume Ranking (2023)
    2.4 Global Measle Vaccine Sales Volume by Company Players (2019-2024)
    2.5 Global Measle Vaccine Average Price by Company (2019-2024)
    2.6 Key Manufacturers Measle Vaccine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Measle Vaccine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Measle Vaccine
    2.9 Measle Vaccine Market Competitive Analysis
        2.9.1 Measle Vaccine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Measle Vaccine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Inactivated Vaccine
        3.1.2 Attenuated Vaccine
    3.2 Global Measle Vaccine Sales Value by Type
        3.2.1 Global Measle Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Measle Vaccine Sales Value, by Type (2019-2030)
        3.2.3 Global Measle Vaccine Sales Value, by Type (%) (2019-2030)
    3.3 Global Measle Vaccine Sales Volume by Type
        3.3.1 Global Measle Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Measle Vaccine Sales Volume, by Type (2019-2030)
        3.3.3 Global Measle Vaccine Sales Volume, by Type (%) (2019-2030)
    3.4 Global Measle Vaccine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Scientific Research
        4.1.3 Others
    4.2 Global Measle Vaccine Sales Value by Application
        4.2.1 Global Measle Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Measle Vaccine Sales Value, by Application (2019-2030)
        4.2.3 Global Measle Vaccine Sales Value, by Application (%) (2019-2030)
    4.3 Global Measle Vaccine Sales Volume by Application
        4.3.1 Global Measle Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Measle Vaccine Sales Volume, by Application (2019-2030)
        4.3.3 Global Measle Vaccine Sales Volume, by Application (%) (2019-2030)
    4.4 Global Measle Vaccine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Measle Vaccine Sales Value by Region
        5.1.1 Global Measle Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Measle Vaccine Sales Value by Region (2019-2024)
        5.1.3 Global Measle Vaccine Sales Value by Region (2025-2030)
        5.1.4 Global Measle Vaccine Sales Value by Region (%), (2019-2030)
    5.2 Global Measle Vaccine Sales Volume by Region
        5.2.1 Global Measle Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Measle Vaccine Sales Volume by Region (2019-2024)
        5.2.3 Global Measle Vaccine Sales Volume by Region (2025-2030)
        5.2.4 Global Measle Vaccine Sales Volume by Region (%), (2019-2030)
    5.3 Global Measle Vaccine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Measle Vaccine Sales Value, 2019-2030
        5.4.2 North America Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Measle Vaccine Sales Value, 2019-2030
        5.5.2 Europe Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Measle Vaccine Sales Value, 2019-2030
        5.6.2 Asia Pacific Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Measle Vaccine Sales Value, 2019-2030
        5.7.2 South America Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Measle Vaccine Sales Value, 2019-2030
        5.8.2 Middle East & Africa Measle Vaccine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Measle Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Measle Vaccine Sales Value
        6.2.1 Key Countries/Regions Measle Vaccine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Measle Vaccine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Measle Vaccine Sales Value, 2019-2030
        6.3.2 United States Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Measle Vaccine Sales Value, 2019-2030
        6.4.2 Europe Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Measle Vaccine Sales Value, 2019-2030
        6.5.2 China Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Measle Vaccine Sales Value, 2019-2030
        6.6.2 Japan Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Measle Vaccine Sales Value, 2019-2030
        6.7.2 South Korea Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Measle Vaccine Sales Value, 2019-2030
        6.8.2 Southeast Asia Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Measle Vaccine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Measle Vaccine Sales Value, 2019-2030
        6.9.2 India Measle Vaccine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Measle Vaccine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Merck
        7.1.1 Merck Company Information
        7.1.2 Merck Introduction and Business Overview
        7.1.3 Merck Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Merck Measle Vaccine Product Offerings
        7.1.5 Merck Recent Development
    7.2 Biovac
        7.2.1 Biovac Company Information
        7.2.2 Biovac Introduction and Business Overview
        7.2.3 Biovac Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Biovac Measle Vaccine Product Offerings
        7.2.5 Biovac Recent Development
    7.3 McKesson Medical
        7.3.1 McKesson Medical Company Information
        7.3.2 McKesson Medical Introduction and Business Overview
        7.3.3 McKesson Medical Measle Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 McKesson Medical Measle Vaccine Product Offerings
        7.3.5 McKesson Medical Recent Development

 8 Industry Chain Analysis
    8.1 Measle Vaccine Industrial Chain
    8.2 Measle Vaccine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Measle Vaccine Sales Model
        8.5.2 Sales Channel
        8.5.3 Measle Vaccine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Measle Vaccine Market Trends
    Table 2. Measle Vaccine Market Drivers & Opportunity
    Table 3. Measle Vaccine Market Challenges
    Table 4. Measle Vaccine Market Restraints
    Table 5. Global Measle Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Measle Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Measle Vaccine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Measle Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Measle Vaccine Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Measle Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Measle Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Measle Vaccine
    Table 13. Global Measle Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Measle Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Measle Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Measle Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Measle Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Measle Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Measle Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Measle Vaccine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Measle Vaccine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Measle Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Measle Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Measle Vaccine Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Measle Vaccine Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Measle Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Measle Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Measle Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Measle Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Measle Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Measle Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Measle Vaccine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Measle Vaccine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Measle Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Measle Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Measle Vaccine Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Measle Vaccine Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Measle Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Measle Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Measle Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Measle Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Measle Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Measle Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Measle Vaccine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Measle Vaccine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Measle Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Measle Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Measle Vaccine Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Measle Vaccine Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Measle Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Measle Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Measle Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Measle Vaccine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Measle Vaccine Sales Volume, (2025-2030) & (K Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Merck Measle Vaccine Product Offerings
    Table 61. Merck Recent Development
    Table 62. Biovac Company Information
    Table 63. Biovac Introduction and Business Overview
    Table 64. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Biovac Measle Vaccine Product Offerings
    Table 66. Biovac Recent Development
    Table 67. McKesson Medical Company Information
    Table 68. McKesson Medical Introduction and Business Overview
    Table 69. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. McKesson Medical Measle Vaccine Product Offerings
    Table 71. McKesson Medical Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Measle Vaccine Downstream Customers
    Table 75. Measle Vaccine Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Measle Vaccine Product Picture
    Figure 2. Global Measle Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Measle Vaccine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Measle Vaccine Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Measle Vaccine Report Years Considered
    Figure 7. Global Measle Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Measle Vaccine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Measle Vaccine Revenue in 2023
    Figure 10. Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Inactivated Vaccine Picture
    Figure 12. Attenuated Vaccine Picture
    Figure 13. Global Measle Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Measle Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Measle Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Measle Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Measle Vaccine Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Scientific Research
    Figure 20. Product Picture of Others
    Figure 21. Global Measle Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Measle Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Measle Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Measle Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Measle Vaccine Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Measle Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Measle Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Measle Vaccine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Measle Vaccine Sales Volume (%), (2019-2030)
    Figure 38. United States Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Measle Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Measle Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Measle Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Measle Vaccine Industrial Chain
    Figure 60. Measle Vaccine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.

The global market for Measle Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation